关注
D.M.W. Balak, MD PhD MSc
D.M.W. Balak, MD PhD MSc
Dermatologist at Leiden University Medical Center
在 lumc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
E Hajdarbegovic, DM Balak
The New England journal of medicine 376 (21), 2092, 2017
619*2017
A benchmark for comparison of cell tracking algorithms
M Maška, V Ulman, D Svoboda, P Matula, P Matula, C Ederra, A Urbiola, ...
Bioinformatics 30 (11), 1609-1617, 2014
4952014
Drug-induced psoriasis: clinical perspectives
DMW Balak, E Hajdarbegovic
Psoriasis (Auckland, NZ) 7, 87, 2017
1632017
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
DS Bakker, LFM Ariens, C van Luijk, J van der Schaft, JL Thijs, ...
British Journal of Dermatology, 2018
1302018
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe …
DMW Balak, MBA van Doorn, RD Arbeit, R Rijneveld, E Klaassen, ...
Clinical Immunology 174, 63-72, 2017
992017
In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine
M Xu, J Deng, K Xu, T Zhu, L Han, Y Yan, D Yao, H Deng, D Wang, Y Sun, ...
THERANOSTICS 9 (9), 2475-2488, 2019
942019
Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review
DMW Balak, GJD Hengstman, A Çakmak, HB Thio
Multiple Sclerosis Journal 18 (12), 1705-1717, 2012
822012
Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature
DMW Balak, S Gerdes, A Parodi, L Salgado-Boquete
Dermatology and Therapy 10 (4), 589-613, 2020
752020
Fumaric acid esters in the management of psoriasis
DMW Balak
Psoriasis Targets Ther 5, 9-23, 2015
612015
Tissue‐resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis
EF Leijten, TS van Kempen, MA Olde Nordkamp, JN Pouw, ...
Arthritis & Rheumatology, 0
61
Refinement of the genetic cause of ATR-16
CL Harteveld, M Kriek, EK Bijlsma, Z Erjavec, D Balak, M Phylipsen, ...
Human genetics 122 (3-4), 283-292, 2007
462007
Efficacy, effectiveness and safety of fumaric acid esters in the treatment of psoriasis: a systematic review of randomized and observational studies
DMW Balak, S Fallah Arani, E Hajdarbegovic, CAF Hagemans, ...
British Journal of Dermatology 175 (2), 250-262, 2016
432016
Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands
DMW Balak, AM Oostveen, MT Bousema, AW Venema, WP Arnold, ...
British Journal of Dermatology 168 (6), 1343-1347, 2013
422013
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis
R Achten, D Bakker, L Ariens, A Lans, J Thijs, J van der Schaft, J de Boer, ...
The Journal of Allergy and Clinical Immunology: In Practice, 2020
372020
Regulated genes in psoriatic skin during treatment with fumaric acid esters
AJ Onderdijk, DMW Balak, EM Baerveldt, EF Florencia, M Kant, JD Laman, ...
British Journal of Dermatology 171 (4), 732-741, 2014
372014
Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study
R Lijnen, E Otters, D Balak, B Thio
Journal of Dermatological Treatment 27 (1), 31-36, 2016
362016
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands
DMW Balak, SC Gouw, I Plug, EP MAUSER‐BUNSCHOTEN, A Vriends, ...
Haemophilia 18 (4), 584-592, 2012
312012
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands
DMW Balak, SC Gouw, I Plug, EP Mauser-Bunschoten, A Vriends, ...
HAEMOPHILIA 17 (2), 367-368, 2011
312011
Highlights of the updated Dutch evidence-and consensus-based guideline on psoriasis 2017.
GE van der Kraaij, DMW Balak, CI Busard, OD van Cranenburgh, ...
The British journal of dermatology 180 (1), 31, 2019
282019
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies
DMW Balak, S Piaserico, I Kasujee
Psoriasis: Targets and Therapy 11, 151, 2021
272021
系统目前无法执行此操作,请稍后再试。
文章 1–20